(MedPage Today) -- Annual low-dose CT lung cancer screening for high-risk individuals doesn't have enough evidence for benefit over harms to be covered by Medicare, an advisory panel concluded. via MedPageToday.com - medical news plus CME for physicians Read More Here..
No comments:
Post a Comment